BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

584 related articles for article (PubMed ID: 17128429)

  • 61. Interval estimation of the mean response in a log-regression model.
    Wu J; Wong AC; Wei W
    Stat Med; 2006 Jun; 25(12):2125-35. PubMed ID: 16220472
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Joint analysis of repeatedly observed continuous and ordinal measures of disease severity.
    Gueorguieva RV; Sanacora G
    Stat Med; 2006 Apr; 25(8):1307-22. PubMed ID: 16217846
    [TBL] [Abstract][Full Text] [Related]  

  • 63. The impact of missing data in a generalized integer-valued autoregression model for count data.
    Alosh M
    J Biopharm Stat; 2009 Nov; 19(6):1039-54. PubMed ID: 20183463
    [TBL] [Abstract][Full Text] [Related]  

  • 64. The impact of dropouts on the analysis of dose-finding studies with recurrent event data.
    Akacha M; Benda N
    Stat Med; 2010 Jul; 29(15):1635-46. PubMed ID: 20552569
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Efficient estimation for patient-specific rates of disease progression using nonnormal linear mixed models.
    Zhang P; Song PX; Qu A; Greene T
    Biometrics; 2008 Mar; 64(1):29-38. PubMed ID: 17501938
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Sensitivity analysis for the estimation of rates of change with non-ignorable drop-out: an application to a randomized clinical trial of the vitamin D3.
    Matsuyama Y
    Stat Med; 2003 Mar; 22(5):811-27. PubMed ID: 12587107
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A multistate Markov chain model for longitudinal, categorical quality-of-life data subject to non-ignorable missingness.
    Cole BF; Bonetti M; Zaslavsky AM; Gelber RD
    Stat Med; 2005 Aug; 24(15):2317-34. PubMed ID: 15977292
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The analysis of incomplete data in the three-period two-treatment cross-over design for clinical trials.
    Richardson BA; Flack VF
    Stat Med; 1996 Jan; 15(2):127-43. PubMed ID: 8614750
    [TBL] [Abstract][Full Text] [Related]  

  • 69. A comparison of adaptive allocation rules for group-sequential binary response clinical trials.
    Morgan CC; Stephen Coad D
    Stat Med; 2007 Apr; 26(9):1937-54. PubMed ID: 16981177
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Simultaneous inference for longitudinal data with detection limits and covariates measured with errors, with application to AIDS studies.
    Wu L
    Stat Med; 2004 Jun; 23(11):1715-31. PubMed ID: 15160404
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Joint modeling of survival and longitudinal data: likelihood approach revisited.
    Hsieh F; Tseng YK; Wang JL
    Biometrics; 2006 Dec; 62(4):1037-43. PubMed ID: 17156277
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Protecting against nonrandomly missing data in longitudinal studies.
    Brown CH
    Biometrics; 1990 Mar; 46(1):143-55. PubMed ID: 2350568
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Analysis of matched case-control data with incomplete strata: applying longitudinal approaches.
    Lin IF; Lai MY; Chuang PH
    Epidemiology; 2007 Jul; 18(4):446-52. PubMed ID: 17525695
    [TBL] [Abstract][Full Text] [Related]  

  • 74. A mixed autoregressive probit model for ordinal longitudinal data.
    Varin C; Czado C
    Biostatistics; 2010 Jan; 11(1):127-38. PubMed ID: 19948742
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Model selection for generalized estimating equations accommodating dropout missingness.
    Shen CW; Chen YH
    Biometrics; 2012 Dec; 68(4):1046-54. PubMed ID: 22463099
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Nonignorable missingness in matched case-control data analyses.
    Cho Paik M
    Biometrics; 2004 Jun; 60(2):306-14. PubMed ID: 15180655
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Meta-analysis of individual patient data versus aggregate data from longitudinal clinical trials.
    Jones AP; Riley RD; Williamson PR; Whitehead A
    Clin Trials; 2009 Feb; 6(1):16-27. PubMed ID: 19254930
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Inference of haplotype effects in case-control studies using unphased genotype and environmental data.
    Chen X; Li Z
    Biom J; 2008 Apr; 50(2):270-82. PubMed ID: 18217697
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Estimation of multiple response rates in phase II clinical trials with missing observations.
    Chang M
    J Biopharm Stat; 2009 Sep; 19(5):791-802. PubMed ID: 20183444
    [TBL] [Abstract][Full Text] [Related]  

  • 80. A note on the use of unbiased estimating equations to estimate correlation in analysis of longitudinal trials.
    Sun W; Shults J; Leonard M
    Biom J; 2009 Feb; 51(1):5-18. PubMed ID: 19197953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.